Stablepoint Partners LLC Lowers Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Stablepoint Partners LLC reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,105 shares of the medical equipment provider’s stock after selling 151 shares during the period. Stablepoint Partners LLC’s holdings in Intuitive Surgical were worth $2,508,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Creekmur Asset Management LLC grew its position in Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 42 shares in the last quarter. Ridgewood Investments LLC acquired a new position in Intuitive Surgical in the 2nd quarter worth $26,000. Able Wealth Management LLC acquired a new stake in shares of Intuitive Surgical during the fourth quarter valued at about $28,000. Delos Wealth Advisors LLC lifted its stake in shares of Intuitive Surgical by 380.0% in the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 57 shares in the last quarter. Finally, LRI Investments LLC purchased a new stake in Intuitive Surgical during the 1st quarter worth approximately $30,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 0.0 %

NASDAQ:ISRG traded down $0.08 during mid-day trading on Monday, hitting $484.70. 38,081 shares of the company’s stock traded hands, compared to its average volume of 1,461,912. The firm has a 50 day moving average of $480.34 and a two-hundred day moving average of $435.19. The firm has a market capitalization of $171.92 billion, a price-to-earnings ratio of 87.51, a price-to-earnings-growth ratio of 5.40 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $254.85 and a 12 month high of $496.48.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, topping analysts’ consensus estimates of $1.54 by $0.24. The company had revenue of $2.01 billion during the quarter, compared to the consensus estimate of $1.97 billion. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The company’s quarterly revenue was up 14.5% on a year-over-year basis. During the same quarter last year, the company earned $1.18 EPS. As a group, equities research analysts expect that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the company. Citigroup increased their target price on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. JPMorgan Chase & Co. raised their price target on Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a report on Friday. Barclays increased their target price on Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a research report on Thursday, July 18th. BTIG Research boosted their target price on shares of Intuitive Surgical from $469.00 to $494.00 and gave the company a “buy” rating in a research note on Wednesday, August 28th. Finally, Evercore ISI raised their target price on Intuitive Surgical from $410.00 to $475.00 and gave the company an “in-line” rating in a research report on Tuesday, October 1st. Six equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $458.35.

Insider Buying and Selling

In other Intuitive Surgical news, insider Mark Brosius sold 2,115 shares of Intuitive Surgical stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $491.91, for a total transaction of $1,040,389.65. Following the completion of the transaction, the insider now directly owns 295 shares of the company’s stock, valued at approximately $145,113.45. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other Intuitive Surgical news, insider Mark Brosius sold 2,115 shares of the business’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $491.91, for a total value of $1,040,389.65. Following the transaction, the insider now directly owns 295 shares in the company, valued at $145,113.45. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Craig H. Barratt sold 1,400 shares of the firm’s stock in a transaction that occurred on Tuesday, July 23rd. The stock was sold at an average price of $458.13, for a total transaction of $641,382.00. The disclosure for this sale can be found here. Insiders sold 53,120 shares of company stock worth $25,528,753 in the last 90 days. 0.90% of the stock is owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.